Get Live Data

Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globallyView Video
Firering Strategic Minerals : from explorer to producer
Firering Strategic Minerals: From explorer to producerView Video

Latest Share Chat

  2. Share Prices
  3. Biopharma Cred. Share Price
  4. Biopharma Cred. Share Regulatory News
  5. STATEMENT RE COHERUS BIOSCIENCES, INC.

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Biopharma Cred. Information

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.84
Bid: 0.842
Ask: 0.846
Change: -0.01 (-1.18%)
Spread: 0.004 (0.475%)
Open: 0.84
High: 0.842
Low: 0.84
Prev. Close: 0.85
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

STATEMENT RE COHERUS BIOSCIENCES, INC.

10 May 2024 15:11

RNS Number : 0397O
BioPharma Credit PLC
10 May 2024
 

BioPharma Credit PLC

10 May 2024

 

 

 

 

BIOPHARMA CREDIT PLC

 

(THE "COMPANY")

 

STATEMENT RE Coherus BIOSCIENCES, Inc.

 

Pharmakon Advisors, LP, the investment manager of the Company, notes the announcement released 9 May 2024 by Coherus Biosciences, Inc. ("Coherus") regarding entering into a combined term loan and product royalty financing agreement with Barings (the "New Financing"). The New Financing allowed Coherus to fully pay off its remaining USD$75 million senior secured term loan, of which the Company had an investment of USD$37.5 million.

 

The Company had previously announced on 10 January 2022 an investment in a senior secured loan to Coherus of up to USD$150 million in up to three tranches. The Company had previously funded US$125 million, of which USD$87.5 million was repaid as referenced in the Company's announcement on 6 February 2024. The remaining USD$37.5 million was repaid to the Company in connection with the New Financing. In connection with this final repayment, the Company received US$39.8 million in total, including USD$2.3 million of accrued interest, and prepayment and make-whole fees.

 

Enquiries:

BioPharma Credit plc

via Link Company Matters Limited

Company Secretary

+44 (0)1392 477 509

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPUBUAUPCGCU
12345678910
Date   Source Headline
18th Feb 20224:37 pmRNSDirector/PDMR Shareholding
14th Feb 202212:30 pmRNSUS$325 MILLION INVESTMENT IN COLLEGIUM
24th Jan 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Jan 20227:00 amRNSNEW INVESTMENT OF UP TO US$150.0 MILLION
21st Dec 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
15th Dec 20217:00 amRNSNEW INVESTMENTS OF UP TO US$112.5 MILLION
19th Nov 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
4th Nov 20217:00 amRNSDividend Declaration
21st Oct 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
11th Oct 202111:39 amRNSDirector Declaration
8th Oct 20217:00 amRNSConfirmation of Delisting from TISE
5th Oct 20217:00 amRNSTransfer of Shares to the Premium Segment
30th Sep 20214:30 pmRNSResult of General Meeting
21st Sep 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
15th Sep 20217:00 amRNSHalf-yearly Report
13th Sep 20217:29 amRNSCREDIT FACILITY UPDATE
27th Aug 20215:30 pmRNSHolding(s) in Company
26th Aug 20215:00 pmRNSHolding(s) in Company
25th Aug 20217:00 amRNSNotice of Half Year Results
20th Aug 20214:00 pmRNSNet Asset Value(s)
19th Aug 20215:30 pmRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSDividend Declaration
10th Aug 20214:45 pmRNSHolding(s) in Company
21st Jul 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
24th Jun 20211:30 pmRNSResult of GM and AGM
21st Jun 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
17th Jun 20213:30 pmRNSResult of Annual General Meeting
4th Jun 20214:30 pmRNSNotice of GM and Change in Proposed Auditor
26th May 20214:00 pmRNSDividend Declaration
25th May 20213:45 pmRNSChange of Auditor
25th May 20213:30 pmRNSNotice of AGM
24th May 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
6th May 202110:30 amRNSDirector/PDMR Shareholding
23rd Apr 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
12th Apr 202111:00 amRNSHolding(s) in Company
24th Mar 20217:00 amRNSNEW INVESTMENT
19th Mar 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
16th Mar 20217:00 amRNSAnnual Financial Report
12th Mar 20215:00 pmRNSReplacement: Dividend Declaration
11th Mar 20215:15 pmRNSDividend Declaration
19th Feb 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
17th Feb 20217:00 amRNSNotice of Full Year Results
22nd Jan 20214:00 pmRNSNet Asset Value(s) and Monthly Factsheet
31st Dec 202012:00 pmRNSDirector/PDMR Shareholding
21st Dec 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
20th Nov 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
12th Nov 20207:00 amRNSDividend Declaration
9th Nov 20207:00 amRNSADDITIONAL INVESTMENT IN EPIZYME
21st Oct 20204:00 pmRNSNet Asset Value(s) and Monthly Factsheet
13th Oct 20203:30 pmRNSHolding(s) in Company
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.